315 related articles for article (PubMed ID: 12692599)
1. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
[TBL] [Abstract][Full Text] [Related]
2. High efficiency retroviral vectors that contain no viral coding sequences.
Yu SS; Kim JM; Kim S
Gene Ther; 2000 May; 7(9):797-804. PubMed ID: 10822307
[TBL] [Abstract][Full Text] [Related]
3. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
4. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
5. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
6. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG; Goff SP; Bank A
Trans Assoc Am Physicians; 1988; 101():212-8. PubMed ID: 3077729
[TBL] [Abstract][Full Text] [Related]
7. Construction and use of a safe and efficient amphotropic packaging cell line.
Markowitz D; Goff S; Bank A
Virology; 1988 Dec; 167(2):400-6. PubMed ID: 2462307
[TBL] [Abstract][Full Text] [Related]
8. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel trans-lentiviral vector that affords predictable safety.
Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
Otto E; Jones-Trower A; Vanin EF; Stambaugh K; Mueller SN; Anderson WF; McGarrity GJ
Hum Gene Ther; 1994 May; 5(5):567-75. PubMed ID: 8054374
[TBL] [Abstract][Full Text] [Related]
11. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
Dupont F; Karim A; Dumon JC; Mine N; Avalosse B
Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
[TBL] [Abstract][Full Text] [Related]
12. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
13. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
[TBL] [Abstract][Full Text] [Related]
14. Characterization of transient expression system for retroviral vector production.
Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
[TBL] [Abstract][Full Text] [Related]
15. Plat-E: an efficient and stable system for transient packaging of retroviruses.
Morita S; Kojima T; Kitamura T
Gene Ther; 2000 Jun; 7(12):1063-6. PubMed ID: 10871756
[TBL] [Abstract][Full Text] [Related]
16. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
[TBL] [Abstract][Full Text] [Related]
17. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
18. Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector.
Lee JT; Yu SS; Han E; Kim S; Kim S
Gene Ther; 2004 Jan; 11(1):94-9. PubMed ID: 14681702
[TBL] [Abstract][Full Text] [Related]
19. Improved retroviral packaging lines derived from spleen necrosis virus.
Martinez I; Dornburg R
Virology; 1995 Apr; 208(1):234-41. PubMed ID: 11831705
[TBL] [Abstract][Full Text] [Related]
20. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
